Gilead’s Trodelvy Basks In TROPiCS With FDA Breast Cancer Nod

Company Lays Out Development Strategy In Q4 Earnings

 
• By Alaric DeArment
  
Gilead announced the approval of Trodelvy for HR+/HER2- metastatic breast cancer • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip